Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-01-31 @ 5:57 PM
Study NCT ID:
NCT01189435
Status:
TERMINATED
Last Update Posted:
2015-11-18
First Post:
2010-08-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: